Clinical trial · Observational
Spectroscopic Magnetic Resonance Imaging of Glioma
NCT03677999CI-TRIAL-00086063MEGA-PRESSwithdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Faculty left the institution
Summary
Brief summary (as posted)
The study is designed to develop and test new Magnetic Resonance Imaging methods that can improve the characterization of brain cancer and facilitate improved clinical care of these participants.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Tumor-Glioma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MEGA-PRESS sequence Magnetic Resonance Spectroscopy | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Brain tumor patients with Glioma
- description
- 1. Men and women scheduled who are diagnosed with glioma who is seeking clinical care for their conditions at the UMN Masonic cancer center. 2. Passed the safety screen for MRI 3. Age 18 or older Participants will receive MEGA-PRESS sequence Magnetic Resonance Spectroscopy during their routined schedule standard of care MRI.
- interventionNames
- Diagnostic Test: MEGA-PRESS sequence Magnetic Resonance Spectroscopy
Primary outcomes (1)
- measure
- The number of brain cancer participants with IDH mutation status
- timeFrame
- 30 minutes
- description
- MEGA-PRESS MRI sequence will be utilized to determine IDH status
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Men and women scheduled who are diagnosed with glioma who is seeking clinical care for their conditions at the UMN Masonic cancer center. 2. Passed the safety screen for MRI 3. Age 18 or older 4. Ability to read and understand English 5. Ability to provide informed consent Exclusion Criteria: 1. Participants who are excluded from the base MRI scan, as determined by the CMRR/CCIR clinical policies are necessarily excluded from this study, as the MRI scan will not be performed. 2. Pregnant women
References
Publications (0)
Data not yet available
No reference posted for this study.